- Missing DNA Linked to Childhood Obesity: Study
- Robotic Hamster Toy May Be Unsafe: Consumer Group
- 10 Million Slim-Fast Drinks Recalled
- Cattle Vaccines May Reduce E. coli Outbreaks in Humans
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Missing DNA Linked to Childhood Obesity: Study
Missing DNA may be linked to obesity in some children, according to British researchers.
They analyzed the DNA of 300 extremely obese children (220 pounds by age 10) and pinpointed a deletion on chromosome 16 that occurs in less than 1 percent of about 1,200 severely obese children, the Associated Press reported.
This deletion means the children lack a gene that the brain needs to respond to the appetite-controlling hormone leptin, said study co-leader Dr. Sadaf Farooqi of Cambridge University.
Children with this deletion "have a very strong drive to eat," and they're "very, very hungry, they always want to eat," Farooqi said, the AP reported.
The study appears online in the journal Nature.
Robotic Hamster Toy May Be Unsafe: Consumer Group
Popular robotic hamster toys contain higher-than-permitted levels of the chemical antimony, which can pose a health threat, says the San Francisco-based consumer group Good Guide.
The group found antimony on the hair (93 parts per million) and nose (106 ppm) of a Zhu Zhu Pets hamster called Mr. Squiggles, the Associated Press reported. The allowable level is 60 ppm.
Zhu Zhu Pets, one of this holiday season's must-have toys, are aimed at 3- to 10-year-olds. The products are safe and have passed rigorous testing, said toy maker Cepia LLC of St. Louis.
"I have been in the toy industry for more than 35 years, and being a father of children myself, I would never allow any substandard or unsafe product to hit the shelves," Cepia CEO Russ Hornsby said in a news release, the AP reported.
On Monday, the U.S. Consumer Product Safety Commission said it had opened an investigation into Zhu Zhu Pets.
"CPSC is looking into the Zhu Zhu pet toy and we will complete our review swiftly. With new safety measures in place for children and toy recalls down from previous years, consumers can have greater confidence when shopping this year and in the CPSC," the agency said in a statement.
10 Million Slim-Fast Drinks Recalled
Possible bacterial contamination has prompted a recall of 10 million cans of Slim-Fast ready-to-drink meal replacements in the United States and Canada.
The products may be contaminated with Bacilus cereus, which can cause vomiting or diarrhea. But the likelihood of a serious reaction to the bacteria in the Slim-Fast drinks is remote, CBS News reported.
The recall includes cans sold individually or in cartons containing four, six or 12 cans that are 11 ounces each.
No other Slim-Fast products, such as meal and snack bars or powdered shakes, are involved in the recall, CBS News reported.
U.S. Food and Drug Administration spokeswoman Rita Chappelle said the recall affects 10 million cans distributed in the United States. Unilever, the maker of Slim-Fast, said Friday that it is still in the process of identifying and correcting the production problem that led to the possible contamination at the company's production facility in Covington, Tenn., CNN reported.
For more on the recall, visit the FDA.
Cattle Vaccines May Reduce E. coli Outbreaks in Humans
Vaccinating cattle against E. coli bacteria could significantly improve the safety of beef and reduce the number of people who become sick and die from tainted beef, according to scientists.
It's believed that E. coli vaccines for cattle could reduce the number of animals carrying the dangerous bacteria by 65 to 75 percent, The New York Times reported.
Two vaccines have been developed commercially, including one made by Minnesota-based Epitopix that received preliminary approval from the U.S. Department of Agriculture in March. The approval means the vaccine can be sold while research continues. About 300,000 head of cattle will be given the vaccine in the coming months as part of a series of studies, said Epitopix general manager James. D. Sandstrom.